Filgotinib for moderately to severely active ulcerative colitis
- DOI
- 10.1080/17474124.2022.2138857
- Published
- 2022-10-03
- Container
- Expert Review of Gastroenterology & Hepatology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/17474124.2022.2138857,
title = {Filgotinib for moderately to severely active ulcerative colitis},
author = {Alessandro Mannucci and Ferdinando D’Amico and Ahmad El Saadi and Laurent Peyrin-Biroulet and Silvio Danese},
year = {2022},
journal = {Expert Review of Gastroenterology \& Hepatology},
doi = {10.1080/17474124.2022.2138857},
url = {https://doi.org/10.1080/17474124.2022.2138857}
}RIS
TY - JOUR TI - Filgotinib for moderately to severely active ulcerative colitis AU - Alessandro Mannucci AU - Ferdinando D’Amico AU - Ahmad El Saadi AU - Laurent Peyrin-Biroulet AU - Silvio Danese PY - 2022 JO - Expert Review of Gastroenterology & Hepatology DO - 10.1080/17474124.2022.2138857 UR - https://doi.org/10.1080/17474124.2022.2138857 ER -
APA
Mannucci, A., D’Amico, F., Saadi, A. E., Peyrin-Biroulet, L., & Danese, S. (2022). Filgotinib for moderately to severely active ulcerative colitis. Expert Review of Gastroenterology & Hepatology. https://doi.org/10.1080/17474124.2022.2138857
Source records
- crossref · retrieved 2026-09-27T03:47:20.043Z